Compare ARK Genomic Revolution ETF (ARKG) vs Google Inc (GOOG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Google Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Google Inc trades at $355.51 (market cap $4.35T). The key difference: Google Inc pays a 0.25% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | GOOG | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $399.06 |
52-Week Low | $23.09 | $181.31 |
Market Cap | — | $4.35T |
Volume | — | 1,511,127 |
Enterprise Value | — | $4.31T |
Dividend Yield | — | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Alphabet (GOOG) trades at $355.03, down 0.34% on the day, with a neutral technical signal and strong fundamental performance. The stock shows robust revenue growth, with 2025 revenue reaching $402.84 billion and net income of $132.17 billion, supported by consistent earnings beats. Analyst consensus is overwhelmingly bullish with an 86.84% buy rating and a $457.50 price target, indicating significant upside potential from current levels.
The outlook for GOOG remains positive driven by AI investments and cloud growth, but risks include regulatory scrutiny and high valuation multiples. With strong cash flow generation and institutional support, the stock presents a compelling opportunity for growth-oriented investors, though market volatility and competitive pressures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Google Inc
Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →
